My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

65.49 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

44 45 Next >

Wall Street is surprisingly most bullish on these 3 Nasdaq stocks

February 14, 2024

Analysts are gradually shifting toward underperforming, less prominent names to find the next big thing - including these three current Wall Street faves

Via MarketBeat

These 2 Growth Stocks Could Soar 33% and 45% According to Wall Street Analysts. Are They Smart Buys Now? ↗

February 13, 2024

Expectations are high for companies making blood sugar monitors and business automation software.

Via The Motley Fool

Wall Street's Next Stock-Split Stocks Are Liable to Be Familiar Names ↗

February 12, 2024

Nine high-profile stocks -- Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk -- have split since mid-2021. Two of these companies appear ready...

Via The Motley Fool

2 No-Brainer Healthcare Stocks to Buy Right Now ↗

February 10, 2024

Companies in the healthcare industry tend to generate returns in a wide range of market environments.

Via The Motley Fool

DexCom: Q4 Earnings Insights ↗

February 08, 2024

Via Benzinga

Prediction: 2 Stocks That Could Trounce the Market ↗

February 08, 2024

They have done it before.

Via The Motley Fool

Earnings Scheduled For February 8, 2024 ↗

February 08, 2024

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.

Via Benzinga

If You Invested $100 In This Stock 15 Years Ago, You Would Have $13,000 Today ↗

February 07, 2024

Via Benzinga

Continuous Glucose Monitor Maker Dexcom's Q4 Profit Triples On Volume Growth And New Customer Additions ↗

February 09, 2024

Dexcom's Q4 2023 performance, reporting $1.03 billion sales, $256.3 million profits, and beating estimates. Dexcom projects $4.15-$4.35 billion in 2024 revenues. William Blair affirms Outperform...

Via Benzinga

DexCom (DXCM) Q4 2023 Earnings Call Transcript ↗

February 08, 2024

DXCM earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results

February 08, 2024

From DexCom, Inc.

Via Business Wire

3 Nasdaq stocks likely to make big earnings splashes

February 07, 2024

Here we look at a few examples of high beta, high standard deviation Nasdaq-100 stocks that are poised to have volatile earnings moves in the near future.

Via MarketBeat

Topics Artificial Intelligence Economy

NASDAQ:DXCM: a strong growth stock preparing for the next leg up?. ↗

January 25, 2024

DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

Evaluating NASDAQ:DXCM for Growth Investment Opportunities. ↗

January 25, 2024

Why the growth investor may take a look at NASDAQ:DXCM.

Via Chartmill

Expert Ratings For DexCom ↗

January 23, 2024

Via Benzinga

2 Phenomenal Stocks to Buy for the New Year ↗

February 03, 2024

These growth stocks are raking in profits and cash as leaders in their respective industries.

Via The Motley Fool

Stryker Stock Sees Relative Strength Rating Jump To 84 ↗

February 01, 2024

The Relative Strength (RS) Rating for Stryker stock jumped into a new percentile Thursday, with a rise from 76 to 84.

Via Investor's Business Daily

These 2 Growth Stocks Are Brilliant Buys for the New Year ↗

January 23, 2024

Business is booming for these stocks, and investors might want to stop and take note.

Via The Motley Fool

Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time

January 23, 2024

From DexCom, Inc.

Via Business Wire

Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today ↗

January 10, 2024

Via Benzinga

A Closer Look at DexCom's Options Market Dynamics ↗

January 08, 2024

Via Benzinga

Don't overlook NASDAQ:DXCM—a stock with solid growth prospects and a reasonable valuation. ↗

January 23, 2024

Investors should take note ofDEXCOM INC (NASDAQ:DXCM), a growth stock that remains attractively priced.

Via Chartmill

MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs

January 22, 2024

With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs.

Via MarketBeat

Topics Earnings

3 Mid-Cap Stocks Poised for a Breakout in 2024 ↗

January 16, 2024

Mid-cap stocks are expected to have a breakout year especially in light of their underperformance in 2023 with these equities looking strong.

Via InvestorPlace

The 3 Best Growth Stocks to Buy in January 2024 ↗

January 14, 2024

The best growth stocks to buy for 2024 with an impressive growth history and solid long-term tailwinds to support 30% EPS growth.

Via InvestorPlace

Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗

January 12, 2024

The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.

Via Investor's Business Daily

Topics ETFs

2 Growth Stocks That Could Make You Richer in 2024 and Beyond ↗

January 09, 2024

Last year wasn't great for either stock, but that's no reason to ignore them.

Via The Motley Fool

History Says the Nasdaq Will Soar in 2024: 1 Stock-Split AI Growth Stock to Buy Now and Hold Forever ↗

January 09, 2024

Nvidia is well positioned to create value for patient shareholders, given its leadership in artificial intelligence chips.

Via The Motley Fool

Topics Artificial Intelligence

3 Stocks to Capitalize on the Telehealth Explosion ↗

January 08, 2024

These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.

Via InvestorPlace

Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales ↗

January 08, 2024

Dexcom beat fourth-quarter sales expectations and issued stronger-than-usual annual guidance.

Via Investor's Business Daily

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.